BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33670477)

  • 1. Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.
    de Sanctis Pecora C; Shitara D
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33670477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral botulinum toxin injection to improve facial asymmetry after acute facial paralysis.
    Kim J
    Otol Neurotol; 2013 Feb; 34(2):319-24. PubMed ID: 23444480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis.
    Lee JM; Choi KH; Lim BW; Kim MW; Kim J
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):71-8. PubMed ID: 25444667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin to improve lower facial symmetry in facial nerve palsy.
    Sadiq SA; Khwaja S; Saeed SR
    Eye (Lond); 2012 Nov; 26(11):1431-6. PubMed ID: 22975654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
    Krohel GB; Cipollo CL; Gaddipati K
    Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term sequelae treatment of peripheral facial paralysis with botulinum toxin type A: Repartition and kinetics of doses used.
    Risoud M; Aljudaibi N; Duquennoy-Martinot V; Guerreschi P
    Ann Chir Plast Esthet; 2016 Feb; 61(1):10-5. PubMed ID: 25953657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UNILATERAL FRONTALIS MUSCLE PARALYSIS: MANAGEMENT WITH BOTULINUM TOXIN A (CASE REPORTS).
    Goldman A; Wollina U
    Georgian Med News; 2018 Feb; (Issue):73-77. PubMed ID: 29578428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
    Wei LA; Diels J; Lucarelli MJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
    Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
    Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromodulator for the Treatment of Congenital Unilateral Lower Lip Palsy.
    Krane NA; Markey JD; Loyo M
    Ann Otol Rhinol Laryngol; 2019 Jan; 128(1):62-65. PubMed ID: 30347990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
    Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.
    Brændvik SM; Roeleveld K; Andersen GL; Raftemo AE; Ramstad K; Majkic-Tajsic J; Lamvik T; Lund B; Follestad T; Vik T
    Trials; 2017 Feb; 18(1):58. PubMed ID: 28166806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A.
    Kongsaengdao S; Maneeton N; Maneeton B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33809486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Practical Use of AbobotulinumtoxinA in Aesthetics.
    Kane MA; Monheit G
    Aesthet Surg J; 2017 May; 37(suppl_1):S12-S19. PubMed ID: 28388719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
    Terzis JK; Karypidis D
    J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of peripheral facial palsy treatment with Botulinum Toxin type A.
    Hernández Herrero D; Abdel Muti García E; López Araujo J; Alfonso Barrera E; Moraleda Pérez S
    J Plast Reconstr Aesthet Surg; 2022 Jan; 75(1):271-277. PubMed ID: 34266804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Weakening of Ipsilateral Depressor Anguli Oris on Smile Symmetry in Postparalysis Facial Palsy.
    Jowett N; Malka R; Hadlock TA
    JAMA Facial Plast Surg; 2017 Jan; 19(1):29-33. PubMed ID: 27658020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous cooling to manage botulinum toxin injection-associated pain in patients with facial palsy: A randomised controlled trial.
    Pucks N; Thomas A; Hallam MJ; Venables V; Neville C; Nduka C
    J Plast Reconstr Aesthet Surg; 2015 Dec; 68(12):1701-5. PubMed ID: 26385134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.